November 14, 2024
SAN ANTONIO — Semaglutide 2.4 mg (Wegovy) was associated with a 22% reduction in annual medical costs in people with overweight/obesity and heart failure, new research […]
November 13, 2024
(Reuters) -Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding […]
November 13, 2024
SAN ANTONIO — Weight loss treatments aren’t reaching many of the people who need them most due to coverage barriers, new data suggested. Findings from three […]
November 13, 2024
(Reuters) -Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a day after those concerns wiped off […]
November 12, 2024
The recent US Food and Drug Administration (FDA) clearance of two over-the-counter (OTC) continuous glucose monitors (CGMs) — Dexcom’s Stelo and Abbott’s Lingo — has sparked interest […]
November 12, 2024
TOPLINE: Long-term treatment with TransCon parathyroid hormone (PTH), a replacement therapy for hypoparathyroidism, demonstrates sustained efficacy and safety in patients with hypoparathyroidism over 52 weeks, with […]
November 12, 2024
Guidance from professional societies on how to handle the risk for pulmonary aspiration during general anesthesia or deep sedation for patients taking glucagon-like peptide 1 receptor […]
November 12, 2024
CHICAGO — Neck hematomas following thyroid surgery, though rare, are highly associated with key factors including comorbid hypertension and blood pressure changes, underscoring the need for […]
November 11, 2024
Doctors have urged caution in linking the weight loss drug tirzepatide to the death of a 58-year-old nurse from Scotland. Susan McGowan, from North Lanarkshire, took […]